Lenvatinib Mesylate Intermediate CAS 205448-65-3 Purity>98.0% (HPLC) Factory
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates Ndi Kuyera Kwambiri
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Dzina la Chemical | Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate |
Mawu ofanana ndi mawu | 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib Wapakati 3 |
Nambala ya CAS | 205448-65-3 |
Nambala ya CAT | Chithunzi cha RF-PI1973 |
Stock Status | Mu Stock, Mphamvu Yopanga 50 MT / Chaka |
Molecular Formula | C12H11NO4 |
Kulemera kwa Maselo | 233.22 |
Boiling Point | 421.0±45.0℃ |
Kuchulukana | 1.267±0.060 g/cm3 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera mpaka Wachikasu |
Kuyera / Kusanthula Njira | >98.0% (HPLC) |
Kutaya pa Kuyanika | <1.00% |
Zotsalira pa Ignition | <0.50% |
Zonse Zonyansa | <2.00% |
H-NMR | Zimagwirizana ndi Kapangidwe |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Pharmaceutical Intermediates |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) ndi yapakatikati ya Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, yogulitsidwa pansi pa dzina la Lenvima pakati pa ena, ndi mankhwala oletsa khansa pochiza mitundu ina ya khansa ya chithokomiro komanso makhansa ena.Inapangidwa ndi Eisai Co. ndipo imakhala ngati multiple kinase inhibitor motsutsana ndi VEGFR1, VEGFR2 ndi VEGFR3 kinases.Lenvatinib imavomerezedwa (kuyambira 2015) pochiza khansa ya chithokomiro yosiyana yomwe imakhala yobwerezabwereza kapena ya metastatic, yopita patsogolo, ndipo sanayankhe chithandizo cha radioactive ayodini (radioiodine).Mu Meyi 2016, bungwe la US Food and Drug Administration (FDA) lidavomereza (mophatikiza ndi everolimus) kuti azichiza matenda amtundu wa renal cell carcinoma kutsatira chithandizo chimodzi choyambirira cha anti-angiogenic.Mankhwalawa amavomerezedwanso ku US ndi ku European Union kwa hepatocellular carcinoma yomwe singathe kuchotsedwa opaleshoni kwa odwala omwe sanalandire chithandizo cha khansa pakamwa kapena jekeseni.